Literature DB >> 23051058

Measles still spreads in Europe: who is responsible for the failure to vaccinate?

P Carrillo-Santisteve1, P L Lopalco.   

Abstract

All countries in the European Region of the World Health Organization (WHO) have renewed their commitment to eliminate measles transmission by 2015. Measles elimination is a feasible target but requires vaccination coverage above 95% with two doses of a measles-mumps-rubella vaccine (MMR) in all population groups and in all geographical areas. Measles has re-emerged in the EU recently, due to suboptimal immunization levels that led to accumulation of susceptible populations over the last years. In fact, while an overall decreasing trend had been observed until 2009, the number of cases increased by a factor of four between 2010 and 2011. According to vaccination coverage data reported to the WHO, between 2000 and 2010, almost 5 million individuals in the EU in the age group 2-12 had not had MMR vaccination. Catch-up vaccination activities for susceptible populations are paramount in order to reach the elimination goal, but only feasible if a multi-component approach is put in place quickly and efficiently. Advocacy and communication are key strategic areas.
© 2012 The Authors. Clinical Microbiology and Infection © 2012 European Society of Clinical Microbiology and Infectious Diseases.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23051058     DOI: 10.1111/j.1469-0691.2012.03982.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  19 in total

1.  The Reemergence of Measles.

Authors:  C L Abad; N Safdar
Journal:  Curr Infect Dis Rep       Date:  2015-12       Impact factor: 3.725

2.  A visual content analysis of vaccine coverage in the print media.

Authors:  Daniel Catalan-Matamoros; Carmen Peñafiel-Saiz
Journal:  Hum Vaccin Immunother       Date:  2019-04-04       Impact factor: 3.452

Review 3.  Zinc supplementation for the treatment of measles in children.

Authors:  Ajibola A Awotiwon; Olabisi Oduwole; Anju Sinha; Charles I Okwundu
Journal:  Cochrane Database Syst Rev       Date:  2017-06-20

4.  Knowledge and risk perception of measles and factors associated with vaccination decisions in subjects consulting university affiliated public hospitals in Lyon, France, after measles infection.

Authors:  Abdoulaye Toure; Mitra Saadatian-Elahi; Daniel Floret; Bruno Lina; Jean-Sebastien Casalegno; Philippe Vanhems
Journal:  Hum Vaccin Immunother       Date:  2014-03-17       Impact factor: 3.452

Review 5.  Vaccination recommendations for adult patients with rheumatic diseases.

Authors:  Mine Durusu Tanrıöver; Servet Akar; Nuran Türkçapar; Ömer Karadağ; İhsan Ertenli; Sedat Kiraz
Journal:  Eur J Rheumatol       Date:  2015-10-28

6.  Exploring the relationship between newspaper coverage of vaccines and childhood vaccination rates in Spain.

Authors:  Daniel Catalan-Matamoros; Carmen Peñafiel-Saiz
Journal:  Hum Vaccin Immunother       Date:  2020-02-04       Impact factor: 3.452

7.  Risk factors for measles in children aged 8 months-14 years in China after nationwide measles campaign: A multi-site case-control study, 2012-2013.

Authors:  Lixin Hao; Chao Ma; Kathleen A Wannemuehler; Qiru Su; Zhijie An; Lisa Cairns; Linda Quick; Lance Rodewald; Yuanbao Liu; Hanqing He; Qing Xu; Yating Ma; Wen Yu; Ningjing Zhang; Li Li; Ning Wang; Huiming Luo; Huaqing Wang; Christopher J Gregory
Journal:  Vaccine       Date:  2016-02-11       Impact factor: 3.641

8.  Antiviral Activity of Favipiravir (T-705) against a Broad Range of Paramyxoviruses In Vitro and against Human Metapneumovirus in Hamsters.

Authors:  D Jochmans; S van Nieuwkoop; S L Smits; J Neyts; R A M Fouchier; B G van den Hoogen
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

9.  Pulmonary measles disease: old and new imaging tools.

Authors:  Fabrizio Albarello; Massimo Cristofaro; Elisa Busi Rizzi; Maria Letizia Giancola; Emanuele Nicastri; Vincenzo Schininà
Journal:  Radiol Med       Date:  2018-07-30       Impact factor: 6.313

10.  Profiling of measles-specific humoral immunity in individuals following two doses of MMR vaccine using proteome microarrays.

Authors:  Iana H Haralambieva; Whitney L Simon; Richard B Kennedy; Inna G Ovsyannikova; Nathaniel D Warner; Diane E Grill; Gregory A Poland
Journal:  Viruses       Date:  2015-03-10       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.